Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01302470 · ClinicalTrials.gov registry record · NA
Comparison of Epicardial Versus Conventional Lead Placement in Cardiac Resynchronization Therapy
A NA study, sponsored by St. Luke's-Roosevelt Hospital Center.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT01302470: Completed NA study, sponsored by St. Luke's-Roosevelt Hospital Center.
NCT01302470 is a NA study that has completed, run by St. Luke's-Roosevelt Hospital Center. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01302470, a NA study, has completed, sponsored by St. Luke's-Roosevelt Hospital Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The primary goal of this study is to evaluate the use of robotically -assisted device leads as a primary strategy for heart resynchronization.This trials aims to compare transvenous lead placement with robotic lead placement for cardiac resynchronization therapy.
Primary Outcome
Heart failure and mortality will be assesd along with six minute hall walk tests
Interventions
- PROCEDURE Primary epicardial placement of left ventricular lead
- PROCEDURE Transvenous placement of left ventricular lead
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2005-02 |
| Est. Completion | 2012-03 |
| Phase | NA |
What the finished NCT01302470 record still lists
NCT01302470 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Primary epicardial placement of left ventricular lead is the first listed.
NCT01302470 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01302470 about?
NCT01302470 is a clinical study titled "Comparison of Epicardial Versus Conventional Lead Placement in Cardiac Resynchronization Therapy". The primary goal of this study is to evaluate the use of robotically -assisted device leads as a primary strategy for heart resynchronization.This trials aims to compare transvenous lead placement with robotic lead placement for cardiac resynchronization therapy.
What is the current status of trial NCT01302470?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2005-02. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01302470?
The interventions under investigation include: Primary epicardial placement of left ventricular lead (PROCEDURE), Transvenous placement of left ventricular lead (PROCEDURE).
Who is sponsoring clinical trial NCT01302470?
This trial is sponsored by St. Luke's-Roosevelt Hospital Center, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01302470's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia